PRQR
Proqr Therapeutics
$1.41
+$0.07 (+5.22%)Oct 28, 2026
Key metrics
The numbers that frame PRQR today
- Market cap
- $151.87M
- Gross margin
- 100%
- EV / Sales
- 1.6
- ROIC
- -92,967.8%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $1.20
- 52wk High
- $3.00
Growth
Revenue and earnings trend for PRQR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PRQR
Is Proqr Therapeutics a good buy?
Hold. Proqr Therapeutics has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Proqr Therapeutics is selling at a very high price.
What is the market capitalization of PRQR?
Proqr Therapeutics's market capitalization is $151.87M.
What is the 52-week high for PRQR stock?
The 52-week high for Proqr Therapeutics is $3.00. The current close of $1.41 is 53% below that high.
What is the 52-week low for PRQR stock?
The 52-week low for Proqr Therapeutics is $1.20. The current close of $1.41 is 17.5% above that low.
Does PRQR stock pay dividends?
Proqr Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PRQR?
Proqr Therapeutics's Debt / Equity ratio is 0.19.